Document is current
Any future updates will be listed below
-
Authors
Ose, Jennifer https://orcid.org/0000-0002-2030-9676
Holowatyj, Andreana N.
Nattenmüller, Johanna
Gigic, Biljana
Lin, Tengda
Himbert, Caroline
Habermann, Nina
Achaintre, David
Scalbert, Augustin
Keski-Rahkonen, Pekka
Böhm, Jürgen
Schrotz-King, Petra
Schneider, Martin
Ulrich, Alexis
Kampman, Ellen
Weijenberg, Matty
Gsur, Andrea
Ueland, Per-Magne
Kauczor, Hans-Ulrich
Ulrich, Cornelia M.
-
Funding
Funding for this research was provided by:
ERA-NET Transcan (01KT1503)
ERA-NET Transcan (JTC 2012)
National Cancer Institute (R01 CA189184)
National Cancer Institute (R01 CA207371)
National Cancer Institute (U01 CA206110)
National Cancer Institute (P30 CA042014)
National Human Genome Research Institute (T32 HG008962)
Österreichischen Akademie der Wissenschaften (1578-B19)
Bundesministerium für Bildung und Forschung (01KT1512)
Institut National Du Cancer (2014-007)
Norges Forskningsråd (236564/H10)
KWF Kankerbestrijding
ZonMw (UW2013-6397)
- License Information
-
More Information
Article History
Received: 30 September 2019
Accepted: 4 May 2020
First Online: 19 May 2020
Compliance with ethical standards
:
: C.M.U. has served as cancer center director oversight over research funded by several pharmaceutical companies, but has not received funding directly herself. The remaining authors declare no conflict of interest.
